Go to content

Publications

266 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Tisagenlecleucel (Kymriah®) for the treatment of DLBCL

Zorginstituut Nederland has completed its assessment of tisagenlecleucel (Kymriah®) for the treatment of DLBCL. Due to its ...

Report | 07-03-2019

Rivaroxaban (Xarelto®) for the prevention of atherothrombotic complications in adult patients with coronary artery disease

Zorginstituut Nederland carried out an assessment of medicinal product rivaroxaban (Xarelto®). The manufacturer requested to ...

Report | 04-03-2019

Patiromer (Veltassa®) for the treatment of hyperkalaemia in adults

Zorginstituut Nederland has carried out an assessment whether patiromer (Veltassa®) is interchangeable with a medicinal product ...

Report | 25-02-2019

Tisagenlecleucel-T (Kymriah®) for the treatment of ALL

Zorginstituut Nederland carried out an assessment of the medicinal product tisagenlecleucel-T (Kymriah®) for the treatment of ...

Report | 18-12-2018

Lesinurad (Zurampic®) for the treatment of hyperuricaemia in gout patients

Zorginstituut Nederland carried out an assessment whether lesinurad (Zurampic®) is interchangeable with any product that is ...

Report | 04-12-2018

Letermovir (Prevymis®) in cases of adult CMV-seropositive recipients of an allogenic haemotopoietic stem cell transplant (HSCT)

Zorginstituut Nederland has carried out an assessment whether letermovir (Prevymis®) is interchangeable with a medicinal product ...

Report | 27-11-2018

Final report FAIR Data feasibility assessment

This is the final report of the FAIR Data part of the FAIR Data and Personal Health Train feasibility assessment. In this ...

Report | 31-10-2018

Final report on the Personal Health Train feasibility assessment

This is the final report of the FAIR Data part of the feasibility assessment on FAIR Data & the Personal Health Train (PHT). In ...

Report | 31-10-2018

Zinnige Zorg in-depth phase appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis - letter to Minister

As part of the Zinnige Zorg programme, Zorginstituut Nederland started the in-depth phase of appropriate post-treatment ...

Letter | 24-10-2018

Zinnige Zorg in-depth phase report appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis

As part of the Zinnige Zorg programme, Zorginstituut Nederland started the in-depth phase of appropriate post-treatment ...

Report | 24-10-2018

Go to